Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Frontiers in Immunology
|
November 17, 2025
Editorial: PANoptosis and its role in T cell-based immunotherapy
Lanyu Jing, Anze Yu
Gland Surgery
|
February 12, 2020
Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid
Wenlong Wang, Qianhui Ouyang, Chaoyang Meng, et al.
Translational Cancer Research
|
February 4, 2022
Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis
Lanyu Jing, Fada Xia, Xin Du, et al.
Experimental Cell Research
|
September 23, 2023
YTHDF1 shapes "cold" tumor and inhibits CD8<sup>+</sup> T cells infiltration and function in breast cancer
Lanyu Jing, Kaiwen Zhou, Zilin Wang, et al.
Cell Death & Disease
|
July 6, 2026
Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer
Lanyu Jing, Zhiping Tan, Ziling Wang, et al.
Biosensors & Bioelectronics
|
June 16, 2026
Machine-learning-assisted artificial olfactory colorimetric sensor array for bladder cancer early detection from urinary volatile organic compounds
Yiquan Xiong, Jun Xiao, Lanyu Jing, et al.
Trends in Biotechnology
|
August 7, 2024
Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance
Tianying Yuan, Xihong Fu, Rongcheng Hu, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8<sup>+</sup> T cell infiltration and functional transition
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Cell Death and Differentiation
|
December 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis
Anze Yu, Liangmin Fu, Lanyu Jing, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Frontiers in Immunology
|
November 17, 2025
Editorial: PANoptosis and its role in T cell-based immunotherapy
Lanyu Jing, Anze Yu
Gland Surgery
|
February 12, 2020
Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid
Wenlong Wang, Qianhui Ouyang, Chaoyang Meng, et al.
Translational Cancer Research
|
February 4, 2022
Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis
Lanyu Jing, Fada Xia, Xin Du, et al.
Experimental Cell Research
|
September 23, 2023
YTHDF1 shapes "cold" tumor and inhibits CD8<sup>+</sup> T cells infiltration and function in breast cancer
Lanyu Jing, Kaiwen Zhou, Zilin Wang, et al.
Cell Death & Disease
|
July 6, 2026
Soluble HER2 promotes chronic antigen-mediated CD8⁺ T-cell dysfunction and limits immunotherapy response in HER2-low triple-negative breast cancer
Lanyu Jing, Zhiping Tan, Ziling Wang, et al.
Biosensors & Bioelectronics
|
June 16, 2026
Machine-learning-assisted artificial olfactory colorimetric sensor array for bladder cancer early detection from urinary volatile organic compounds
Yiquan Xiong, Jun Xiao, Lanyu Jing, et al.
Trends in Biotechnology
|
August 7, 2024
Bioprinted, spatially defined breast tumor microenvironment models of intratumoral heterogeneity and drug resistance
Tianying Yuan, Xihong Fu, Rongcheng Hu, et al.
Journal for Immunotherapy of Cancer
|
October 6, 2023
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8<sup>+</sup> T cell infiltration and functional transition
Anze Yu, Jiao Hu, Liangmin Fu, et al.
Cell Death and Differentiation
|
December 13, 2024
Methionine-driven YTHDF1 expression facilitates bladder cancer progression by attenuating RIG-I-modulated immune responses and enhancing the eIF5B-PD-L1 axis
Anze Yu, Liangmin Fu, Lanyu Jing, et al.
Page
of 1